Pyridoxine-Dependent Seizures: Magnetic Resonance Spectroscopy Findings

Abstract

Pyridoxine-dependent seizures are an extremely rare genetic disorder. Early diagnosis and treatment are important for the prevention of permanent brain damage. Elevated levels of glutamate and decreased levels of γ-aminobutyric acid (GABA) in the frontal and parietal cortices are among the characteristic features of this disorder. These metabolic abnormalities eventually lead to seizures and neuronal loss. In this case report, we present magnetic resonance spectroscopy findings of a 9-year-old girl with pyridoxine-dependent seizures with mental retardation. The N-acetyl-aspartate-to-creatine ratio was found to be decreased in the frontal and parieto-occipital cortices, which could indicate neuronal loss. Magnetic resonance spectroscopy could be a useful tool in the neuroimaging evaluation for assessment of parenchymal changes despite a normal-appearing brain magnetic resonance image in patients with pyridoxine-dependent seizures. (J Child Neurol 2004;19:75—78).

Get full access to this article

View all access options for this article.

References

Shih JJ , Kornblum H. , Shewmon DA : Global brain dysfunction in an infant with pyridoxine dependency: Evaluation with EEG, evoked potentials, MRI, and PET. Neurology 1996;47:824—826.

Gospe SM Jr , Hecht ST : Longitudinal MRI findings in pyridoxine-dependent seizures. Neurology 1998;51:74—78.

Lott IT , Coulombe T. , Di Paolo RV , et al: Vitamin B6-dependent seizures: Pathology and chemical findings in brain. Neurology 1978;28:47—54.

Cecil KM , Jones BV : Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001; 12:435-452.

Alkan A. , Sarac K. , Kutlu, R. , et al: Early and late state subacute sclerosing panencephalitis: Chemical shift imaging and single voxel MR spectroscopy. AJNR Am Neuroradiol 2003;24:501—506.

Hunt AD , Stokes J. , Mccorry WW , et al: Pyridoxine dependency: Report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 1954;13:140—145.

Haenggeli CA , Girardin E. , Paunier L. : Pyridoxine-dependent seizures, clinical and therapeutic aspects. Eur J Pediatr 1991 ;150:452—455.

Goto T. , Matsuo N. , Takahashi T. : CSF glutamate/GABA concentrations in pyridoxine-dependent seizures: Etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control. Brain Dev 2001;23:24—29.

Baumeister FA , Gsell W. , Shin YS , Egger J. : Glutamate in pyridoxine-dependent epilepsy: Neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. Pediatrics 1994;94:318—321.

10.

Meldrum BS : Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol 1993;3:405—412.

11.

Jardim LB , Pires RF , Martins CE , et al: Pyridoxine-dependent seizures associated with white matter abnormalities . Neuropediatrics 1994,25:259—261.